Atlanta, GA – Scibility Media – 11/04/2014.
This article discusses two companies: Health Net, Inc.(NYSE:HNT) and WABCO Holdings Inc.(NYSE:WBC)
Health Net, Inc.(NYSE:HNT) announced on Monday morning that it had recorded a third quarter 2014 GAAP net loss of $8.9 million, or $0.11 per share. This figure represents a substantial loss from the GAAP net income of $66.8 million, or $0.83 per diluted share, recorded during the same period of the previous fiscal year.
However, the company did announce ten minutes before the financial results release that it had entered into a master services agreement with Cognizant Healthcare Services, LLC, through which the latter will provide consulting, technology, and administrative services. The company has a market capitalization of $3.84 billion and 80.31 million tradeable shares.
WABCO Holdings Inc.(NYSE:WBC) is a Belgium-based auto parts company that provides electronic and mechatronic products for commercial truck, trailer, bus, and passenger car manufacturers. The company’s products include pneumatic anti-lock braking systems, electronic braking systems, and air disc brakes.
The company reported its third quarter 2014 financial results on Oct. 24th, 2014. The numbers included a diluted earnings per share figure of $1.44, which is eighteen cents above the $1.26 figure recorded during the same period of the previous fiscal year. That being said, WABCO Holdings lowered its sales growth guidance for full year 2014 from 6 to 9 percent to 5.5 to 6.5 percent.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to firstname.lastname@example.org and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.